1. Introduction
Medicinal plants, formally recognized for containing bioactive substances useful in disease treatment, have been integral to healthcare for millennia (Kujawska & Pardo-De-Santayana, 2015; Sofowora et al., 2013). Derivation of therapeutic agents from plants has attracted global attention due to their perceived safety, accessibility, and cost-effectiveness. Herbal medicines are typically prepared from leaves, roots, bark, seeds, or flowers and administered via oral, inhalation, or topical routes (Petrovska, 2012). Beyond their cultural and historical relevance, medicinal plants remain a cornerstone for drug discovery and development, serving as reservoirs of bioactive compounds with proven pharmacological potential (Krishnapriya et al., 2022).
The therapeutic activities of medicinal plants are primarily attributed to their phytochemical constituents such as alkaloids, flavonoids, tannins, terpenoids, saponins, phenolic compounds, and essential oils. These natural compounds not only contribute to traditional healing practices but also form the structural backbone of many modern pharmaceuticals (Veeresham, 2012). Historically, the medicinal use of plants emerged through empirical observation, where beneficial and toxic species were distinguished through trial and error. Knowledge was preserved through generations, forming the basis of traditional medicine across diverse cultures. Despite the scientific progress of synthetic chemistry, there remains strong interest in plant-based bioactive compounds, both for their direct therapeutic use and as lead molecules for novel drug design (Kaggwa et al., 2022).
Hyptis suaveolens (L.) Poit., commonly referred to as “mosquito plant,” represents one such species of significant ethnomedicinal value. Native to tropical and subtropical regions, H. suaveolens is often considered a pervasive weed but has been documented to possess diverse pharmacological properties. Its leaves are rich in pharmacologically active secondary metabolites with antispasmodic, anti-colic, anti-rheumatic, and anti-fertility effects (Li et al., 2020). Additional reports highlight sedative, diuretic, aromatic, anti-inflammatory, anti-pyretic, anti-catarrhal, anti-rheumatic, anti-soporific, and anti-cancer activities (Bhattacharya et al., 2018). The essential oils of H. suaveolens have demonstrated antimicrobial and antifungal properties, while the roots contain ursolic acid, a triterpenoid with documented anti-retroviral potential through inhibition of retroviral integrases and proteases (Swamy et al., 2016; Kaur et al., 2020; Kumar et al., 2023). Phytochemical studies of the leaves have revealed alkaloids as the dominant metabolites, followed by tannins and saponins (Mishra et al., 2021).
Although H. suaveolens is widely used in traditional medicine, its chemical diversity and antimicrobial potential remain underexplored compared to other medicinal plants of global relevance. Reports on its essential oil profile and non-volatile metabolites are still limited, particularly in relation to their activity against clinically important pathogens. This represents a significant knowledge gap, given the urgent global demand for alternative antimicrobial agents in the face of rising antimicrobial resistance.
Here, we investigate the volatile and non-volatile constituents of H. suaveolens leaves and evaluate their antimicrobial activities against selected pathogens. Specifically, essential oils were extracted by hydrodistillation using a Clevenger apparatus, while methanol was employed for solvent extraction of non-volatile compounds. The antimicrobial potential of both extracts was subsequently tested to establish their comparative efficacy.
2. Materials and Methods
Plant Material
Fresh leaves of Hyptis suaveolens were collected from the campus of Adekunle Ajasin University, Akungba Akoko, Ondo State, Nigeria. The plant was authenticated by Dr. Obembe, Department of Plant Science and Biotechnology, Adekunle Ajasin University, and a voucher specimen was deposited in the departmental herbarium.
Test Microorganisms
Clinical isolates of Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus, Klebsiella pneumoniae, and Candida albicans were obtained from the Microbiology Laboratory of Adekunle Ajasin University. The strains were subcultured on nutrient agar and maintained at 4 °C until use.
Standardization of Inoculum
The bacterial inocula were standardized to 0.5 McFarland turbidity standard, corresponding to ~1.5 × 10^8 CFU/mL, by adjusting the turbidity of 24 h broth cultures with sterile saline (Samanta, 2020).
Antimicrobial Susceptibility Testing
The antimicrobial activity of extracts was evaluated using the agar well diffusion method according to Clinical and Laboratory Standards Institute (CLSI) guidelines (Humphries et al., 2021). Mueller–Hinton agar was seeded with standardized inocula of test organisms, and wells (5 mm diameter) were bored aseptically. Each well received 100 μL of extract solution at different concentrations. Erythromycin (10 μg/mL) served as the positive control, while solvent served as the negative control. Plates were incubated at 37 °C for 24 h, and the zones of inhibition were measured in millimeters.
Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)
MICs were determined by macro-broth dilution following the method of Parvekar et al. (2020) with slight modifications. Serial dilutions of extracts (50–3.125 mg/mL) were prepared in Mueller–Hinton broth. MIC was defined as the lowest concentration with no visible growth after 24 h incubation at 37 °C. To determine MBC, aliquots from MIC tubes showing no visible growth were plated onto Mueller–Hinton agar. MBC was recorded as the lowest concentration yielding no colony growth after incubation. For Candida albicans, Sabouraud dextrose broth and agar were used.
3. Results and Discussion
Antimicrobial Activity: Zone of Inhibition
Both the methanolic extract and essential oil of
Hyptis suaveolens demonstrated inhibitory activity against all six tested clinical isolates. The methanolic extract consistently showed higher antimicrobial efficacy than the essential oil (
Table 3). The strongest activity was observed against
Candida albicans (32 mm zone of inhibition), while the weakest effect was noted against
Staphylococcus aureus (27 mm). These results corroborate earlier findings by Pachkore et al. (2011), who also reported broad-spectrum activity of
H. suaveolens extracts.
The superior performance of the methanolic extract relative to the essential oil likely reflects the higher solubility and wider range of bioactive phytochemicals recovered by methanol compared with volatile oil distillation. Among the tested organisms, Pseudomonas aeruginosa exhibited the lowest susceptibility, particularly to the essential oil, which is consistent with its known intrinsic resistance mechanisms such as biofilm formation, efflux activity, and encapsulation (Bonilla-Landa et al., 2022; Bashir, 2019). Overall, the results highlight that H. suaveolens contains compounds with notable antimicrobial activity, with methanolic extracts being especially potent against yeast and Gram-negative bacteria.
Minimum Inhibitory Concentration (MIC)
The methanolic extract of
Hyptis suaveolens inhibited all six test organisms at every concentration tested, including the lowest level (3.125 mg/mL), indicating strong and consistent antimicrobial potency (
Table 4). In contrast, the essential oil displayed variable inhibition across the organisms (
Table 5).
E. coli and
Pseudomonas aeruginosa were inhibited at higher concentrations (≥12.5 mg/mL) but not at the lowest levels.
Candida albicans and
Staphylococcus aureus were inhibited at 25–50 mg/mL, while
Bacillus cereus and
Klebsiella pneumoniae required relatively higher concentrations compared with the methanolic extract. Overall, the methanolic extract demonstrated broader and more consistent inhibitory activity than the essential oil. These findings align with earlier studies (Bashir et al., 2019; Moreira et al., 2010), which reported stronger antimicrobial performance of polar solvent extracts compared to essential oils. Variations in susceptibility across organisms may reflect structural differences in microbial cell walls and membranes.
Minimum Bactericidal Concentration (MBC)
In this study, the methanolic extract of Hyptis suaveolens demonstrated bactericidal activity against the tested clinical isolates. Complete eradication was observed for E. coli and Pseudomonas aeruginosa at 50 and 25 mg/L. Candida albicans required 12.5 mg/L for bactericidal effect, while Bacillus cereus was eliminated at 50 and 25 mg/L. Klebsiella pneumoniae succumbed only at 12.5 mg/L, and Staphylococcus aureus was killed at 50 and 25 mg/L. Similarly, the essential oil showed bactericidal effects, with E. coli and P. aeruginosa eradicated at 50 and 25 mg/L. Candida albicans and Staphylococcus aureus required 12.5 mg/L, while B. cereus was eliminated at 50 and 25 mg/L. K. pneumoniae was the least susceptible, responding only at the higher concentrations. These variations in MBC values highlight differences in microbial susceptibility, likely influenced by structural and physiological features such as cell wall composition and membrane permeability (Mirković et al., 2025). Overall, both methanol extract and essential oil of H. suaveolens exhibited promising bactericidal potential across bacterial and fungal pathogens, though activity was strain-dependent.
Table 6.
Minimum bactericidal concentration (MBC) of the essential oil of Hyptis suaveolens.
Table 6.
Minimum bactericidal concentration (MBC) of the essential oil of Hyptis suaveolens.
| Isolate |
50 |
25 |
12.5 |
6.25 |
3.125 |
| E. coli |
– |
– |
+ |
+ |
+ |
| Pseudomonas aeruginosa |
– |
– |
+ |
+ |
+ |
| Candida albicans |
– |
– |
– |
+ |
+ |
| Bacillus cereus |
– |
– |
– |
+ |
+ |
| Klebsiella pneumoniae |
– |
– |
+ |
+ |
+ |
| Staphylococcus aureus |
– |
– |
– |
+ |
+ |
Table 7.
Minimum bactericidal concentration (MBC) of the methanolic extract of Hyptis suaveolens.
Table 7.
Minimum bactericidal concentration (MBC) of the methanolic extract of Hyptis suaveolens.
| Isolate |
50 |
25 |
12.5 |
6.25 |
3.125 |
| E. coli |
– |
– |
+ |
+ |
+ |
| Pseudomonas aeruginosa |
– |
– |
+ |
+ |
+ |
| Candida albicans |
– |
– |
– |
+ |
+ |
| Bacillus cereus |
– |
– |
– |
+ |
+ |
| Klebsiella pneumoniae |
– |
– |
– |
+ |
+ |
| Staphylococcus aureus |
– |
– |
– |
+ |
+ |
4. Conclusion
The present study demonstrates that Hyptis suaveolens contains diverse bioactive compounds with significant antimicrobial activity. Both methanolic and essential oil extracts inhibited and killed a range of bacterial and fungal pathogens, with the methanolic extract showing superior efficacy and broader spectrum. These findings support the potential of H. suaveolens as a source of natural antimicrobial agents, though activity varied by strain and warrants further pharmacological evaluation.
References
- Bashir, D. S. F. (2019). Antibacterial Activity of Hyptis suaveolens Leaves Extract on some Selected Clinical Isolates. Antibacterial Activity of Hyptis Suaveolens Leaves Extract on Some Selected Clinical Isolates. https://www.academia.edu/51034008/Antibacterial_Activity_of_Hyptis_suaveolens_Leaves_Extract_on_some_Selected_Clinical_Isolates.
- Bezerra, J. W. A., Costa, A. R., da Silva, M. A. P., Rocha, M. I., Boligon, A. A., da Rocha, J. B. T., … Kamdem, J. P. (2017). Chemical composition and toxicological evaluation of Hyptis suaveolens (L.) Poiteau (LAMIACEAE) in Drosophila melanogaster and Artemia salina. Suid-Afrikaanse Tydskrif Vir Plantkunde [South African Journal of Botany], 113, 437–442. [CrossRef]
- Bhattacharya, A., Tiwari, P., Sahu, P. K., & Kumar, S. (2018). A Review of the Phytochemical and Pharmacological Characteristics of Moringa oleifera. Journal of Pharmacy & Bioallied Sciences, 10(4), 181–191. [CrossRef]
- Bonilla-Landa, I., José María Callejas-Linares, Marian, E., Feliza Ramón Farías, Guevara-Valencia, M., Monribot-Villanueva, J. L., & José Antonio Guerrero-Analco. (2022). Actividad antibacteriana y perfil fenólico del extracto metanólico de las partes aéreas de Hyptis suaveolens (Lamiaceae). Acta Botanica Mexicana, 129. [CrossRef]
- Chung, N. T., Huong, L. T., Dai, D. N., & Ogunwande, I. A. (2020). Chemical Compostions of Essential Oils and Antimicrobial Activity of Hyptis suaveolens (L.) Poit. (Lamiaceae) from Vietnam. European Journal of Medicinal Plants, 114–123. [CrossRef]
- Humphries, R., Bobenchik, A. M., Hindler, J. A., & Schuetz, A. N. (2021). Overview of changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st edition. Journal of Clinical Microbiology, 59(12), e0021321. [CrossRef]
- Kaggwa, B., Kyeyune, H., Munanura, E. I., Anywar, G., Lutoti, S., Aber, J., … Ogwang, P. E. (2022). Safety and efficacy of medicinal plants used to manufacture herbal products with regulatory approval in Uganda: A cross-sectional study. Evidence-Based Complementary and Alternative Medicine: eCAM, 2022, 1304839. [CrossRef]
- Kaur, R., Sharma, P., Gupta, G. K., Ntie-Kang, F., & Kumar, D. (2020). Structure-activity-relationship and mechanistic insights for anti-HIV natural products. Molecules (Basel, Switzerland), 25(9), 2070. [CrossRef]
- Krishnapriya, Sasikumar, P., Aswathy, M., Prem, P. T., Radhakrishnan, K. V., & Baby Chakrapani, P. S. (2022). Plant derived bioactive compounds and their potential to enhance adult neurogenesis. Phytomedicine plus: International Journal of Phytotherapy and Phytopharmacology, 2(1), 100191. [CrossRef]
- Kujawska, M., & Pardo-de-Santayana, M. (2015). Management of medicinally useful plants by European migrants in South America. Journal of Ethnopharmacology, 172, 347–355. [CrossRef]
- Kumar, N., Khanna, A., Kaur, K., Kaur, H., Sharma, A., & Bedi, P. M. S. (2023). Quinoline derivatives volunteering against antimicrobial resistance: rational approaches, design strategies, structure activity relationship and mechanistic insights. Molecular Diversity, 27(4), 1905–1934. [CrossRef]
- Li, R., Tang, G., Liu, X., Li, J., Wang, D., & Ji, S. (2020). An ethnopharmacological review of Hyptis suaveolens (L.) Poit. Tropical Journal of Pharmaceutical Research: TJPR, 19(7), 1541–1550. [CrossRef]
- McNeil, M., Facey, P., & Porter, R. (2011). Essential oils from the Hyptis genus--a review (1909-2009). Natural Product Communications, 6(11), 1775–1796. [CrossRef]
- Mirković, S., Martinović, M., Tadić, V. M., Nešić, I., Aleksandra Stolić Jovanović, & Žugić, A. (2025). Antimicrobial and Antioxidant Activity of Essential Oils from Selected Pinus Species from Bosnia and Herzegovina. Antibiotics, 14(7), 677–677. [CrossRef]
- Mishra, P., Sohrab, S., & Mishra, S. K. (2021). A review on the phytochemical and pharmacological properties of Hyptis suaveolens (L.) Poit. Future Journal of Pharmaceutical Sciences, 7(1), 65. [CrossRef]
- Moreira, A. C. P., Lima, E. de O., Wanderley, P. A., Carmo, E. S., & Souza, E. L. de. (2010). Chemical composition and antifungal activity of Hyptis suaveolens (L.) poit leaves essential oil against Aspergillus species. Brazilian Journal of Microbiology, 41(1), 28–33. [CrossRef]
- Pachkore, G. L., D.A. Dhale, & Dharasurkar, A. N. (2011). Antimicrobial and phytochemical screening of Hyptis suaveolens (L.Poit) Lamiaceae. 1(4), 1-03. https://www.researchgate.net/publication/215728752_Antimicrobial_and_phytochemical_screening_of_Hyptis_suaveolens_LPoit_Lamiaceae.
- Parvekar, P., Palaskar, J., Metgud, S., Maria, R., & Dutta, S. (2020). The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of silver nanoparticles against Staphylococcus aureus. Biomaterial Investigations in Dentistry, 7(1), 105–109. [CrossRef]
- Petrovska, B. B. (2012). Historical review of medicinal plants’ usage. Pharmacognosy Reviews, 6(11), 1–5. [CrossRef]
- Samanta, S. (2022). Potential bioactive components and health promotional benefits of tea (Camellia sinensis). Journal of the American Nutrition Association, 41(1), 65–93. [CrossRef]
- Sofowora, A., Ogunbodede, E., & Onayade, A. (2013). The role and place of medicinal plants in the strategies for disease prevention. African Journal of Traditional, Complementary, and Alternative Medicines, 10(5), 210–229. [CrossRef]
- Swamy, M. K., Akhtar, M. S., & Sinniah, U. R. (2016). Antimicrobial properties of plant essential oils against human pathogens and their mode of action: An updated review. Evidence-Based Complementary and Alternative Medicine: eCAM, 2016, 3012462. [CrossRef]
- Tonzibo, Z. F., Florence, A. B., Bedi, G., & Jean-Claude Chalchat. (2009). Chemical composition of essential oil of Hyptis suaveolens from Côte d’Ivoire. European Journal of Scientific Research, 38(4), 565–571. https://www.researchgate.net/publication/261955341_Chemical_composition_of_essential_oil_of_Hyptis_suaveolens_from_Cote_d.
- Veeresham, C. (2012). Natural products derived from plants as a source of drugs. Journal of Advanced Pharmaceutical Technology & Research, 3(4), 200–201. [CrossRef]
Table 3.
Zone of inhibition (mm) of clinical isolates exposed to methanolic extract and essential oil of Hyptis suaveolens.
Table 3.
Zone of inhibition (mm) of clinical isolates exposed to methanolic extract and essential oil of Hyptis suaveolens.
| Isolate |
E. coli |
Pseudomonas aeruginosa |
Candida albicans |
Bacillus cereus |
Klebsiella pneumoniae |
Staphylococcus aureus |
| Essential oil |
24 |
20 |
23 |
21 |
20 |
22 |
| Methanolic extract |
28 |
29 |
32 |
30 |
30 |
27 |
| Control |
30 |
28 |
32 |
50 |
30 |
32 |
Table 4.
Minimum inhibitory concentration (MIC) of methanolic extract of Hyptis suaveolens.
Table 4.
Minimum inhibitory concentration (MIC) of methanolic extract of Hyptis suaveolens.
| Isolate |
50 |
25 |
12.5 |
6.25 |
3.125 |
| E. coli |
+ |
+ |
+ |
+ |
+ |
| Pseudomonas aeruginosa |
+ |
+ |
+ |
+ |
+ |
| Candida albicans |
+ |
+ |
+ |
+ |
+ |
| Bacillus cereus |
+ |
+ |
+ |
+ |
+ |
| Klebsiella pneumoniae |
+ |
+ |
+ |
+ |
+ |
| Staphylococcus aureus |
+ |
+ |
+ |
+ |
+ |
Table 5.
Minimum inhibitory concentration (MIC) of essential oil of Hyptis suaveolens.
Table 5.
Minimum inhibitory concentration (MIC) of essential oil of Hyptis suaveolens.
| Isolate |
50 |
25 |
12.5 |
6.25 |
3.125 |
| E. coli |
+ |
+ |
+ |
– |
– |
| Pseudomonas aeruginosa |
+ |
+ |
+ |
– |
– |
| Candida albicans |
+ |
+ |
+ |
– |
– |
| Bacillus cereus |
+ |
+ |
– |
– |
– |
| Klebsiella pneumoniae |
+ |
+ |
– |
– |
– |
| Staphylococcus aureus |
+ |
+ |
+ |
– |
– |
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).